| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 10/28/2004 | WO2004066925A3 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same |
| 10/28/2004 | WO2004064716A3 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders |
| 10/28/2004 | WO2004037789A3 Methylene urea derivatives as raf-kinase inhibitors |
| 10/28/2004 | WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/28/2004 | WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 10/28/2004 | WO2003077840A3 Method of modulating inflammatory response |
| 10/28/2004 | WO2003030833A3 Angiopoietin-2 specific binding agents |
| 10/28/2004 | WO2001039723A3 Triazospiro compounds having nociceptin receptor affinity |
| 10/28/2004 | US20040215292 Photodynamic treatment of targeted cells |
| 10/28/2004 | US20040215023 Crystal and process for producing the same |
| 10/28/2004 | US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders |
| 10/28/2004 | US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis |
| 10/28/2004 | US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same |
| 10/28/2004 | US20040214886 for the treatment and/or prophylaxis of diseases, in particular, states of pain and neurodegenerative disorders |
| 10/28/2004 | US20040214864 Novel compounds |
| 10/28/2004 | US20040214853 Analgesics; side effect reduction; antidiabetic agents; central nervous system disorders |
| 10/28/2004 | US20040214849 via injection or intravenous drip |
| 10/28/2004 | US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer |
| 10/28/2004 | US20040214839 administering prostaglandin or agonist thereof and type IV selective phosphodiesterase (PDE) inhibitor to induce tolerance to antigens |
| 10/28/2004 | US20040214816 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
| 10/28/2004 | US20040214794 perorally or rectally administering an effective amount of a lipopolysaccharide isolated from Escherichia coli |
| 10/28/2004 | US20040214768 immunogenic polypeptides containing both self and non-self amino acid segments, used for prophylaxis of sepsis, cardiovascular disorders, adult respiratory distress syndrome, nephritis, graft rejection, arthritis, asthma, inflammatory bowel disease, multiple sclerosis and arteriosclerosis in mammals |
| 10/28/2004 | US20040214759 Compositions and methods of use for a fibroblast growth factor |
| 10/28/2004 | US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 10/28/2004 | US20040214229 Amino acid sequences for use in diagnosis, prevention and treatment of sepsis and infections |
| 10/28/2004 | US20040214190 Mammalian c-type lectins |
| 10/28/2004 | US20040213839 by maintaining the agent, a flavorant, and a cellulosic material in relatively close physical contact with one another in an oral dosage form |
| 10/28/2004 | US20040213797 Conjugates for the modulation of immune responses |
| 10/28/2004 | US20040213793 nucleic acid molecule encoding a transmembrane TEM1; Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a Tumor Endothelial Markers (TEMs) protein; polycystic kidney disease; psoriasis |
| 10/28/2004 | US20040213772 Peptide factor |
| 10/28/2004 | CA2522084A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 10/28/2004 | CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling |
| 10/28/2004 | CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | CA2521826A1 Recombinant il-9 antibodies and uses thereof |
| 10/27/2004 | EP1471143A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 10/27/2004 | EP1471055A1 6-phenylpyridyl-2-amine derivatives |
| 10/27/2004 | EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 10/27/2004 | EP1470826A1 Decoy-containing pharmaceutical compositions and method of using the same |
| 10/27/2004 | EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 10/27/2004 | EP1470257A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470256A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE /GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470249A2 Effectors of innate immunity |
| 10/27/2004 | EP1470231A2 Methods of obtaining isoform specific expression in mammalian cells |
| 10/27/2004 | EP1470154A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 10/27/2004 | EP1470150A2 Corticosteroids nitrate derivatives |
| 10/27/2004 | EP1470148A2 Double-stranded oligonucleotides |
| 10/27/2004 | EP1470144A2 Oligonucleotides comprising alternating segments and uses thereof |
| 10/27/2004 | EP1470143A1 Compounds that inhibit factor xa activity |
| 10/27/2004 | EP1470141A2 Glycosulfopeptide inhibitors and methods of use thereof |
| 10/27/2004 | EP1470138A1 Mmp inhibitors |
| 10/27/2004 | EP1470137A1 Edg receptor agonists |
| 10/27/2004 | EP1470124A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES |
| 10/27/2004 | EP1470112A1 Substituted pyridazinones as inhibitors of p38 |
| 10/27/2004 | EP1469887A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 10/27/2004 | EP1469884A1 Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders |
| 10/27/2004 | EP1469882A2 Treatment of ms with goat serum |
| 10/27/2004 | EP1469880A2 Method for reducing morbidity and mortality in critically ill patients |
| 10/27/2004 | EP1469857A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis |
| 10/27/2004 | EP1469856A2 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 10/27/2004 | EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators |
| 10/27/2004 | EP1469846A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 10/27/2004 | EP1469842A2 Bicyclic cb2 cannabinoid receptor ligands |
| 10/27/2004 | EP1469835A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 10/27/2004 | EP1469834A1 Multi-stage oral drug controlled-release system |
| 10/27/2004 | EP1387701B1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
| 10/27/2004 | EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP1246791B1 Aminomethyl-phenyl-cyclohexanone derivatives |
| 10/27/2004 | EP1237578A4 Micro-cluster liquids and methods of making and using them |
| 10/27/2004 | EP1204407B1 Implantable active ingredient depot |
| 10/27/2004 | EP1150952B1 Indole derivatives and their use as mcp-1 receptor antagonists |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/27/2004 | EP0918795B1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 10/27/2004 | EP0831791B1 Delivery of drugs to the lower gi tract |
| 10/27/2004 | EP0813544B1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 10/27/2004 | CN1541335A EPF receptor assays, compounds and therapeutic compsns. |
| 10/27/2004 | CN1541266A FCE fusion proteins for treatment of allergy and asthma |
| 10/27/2004 | CN1541224A Antagonistic anti-hTNFSF13b Human antibodies |
| 10/27/2004 | CN1541217A Chemical compounds |
| 10/27/2004 | CN1541214A Novel compounds |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541208A 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/27/2004 | CN1541106A Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases |
| 10/27/2004 | CN1541105A Combination therapies using vitamin B12 and interferon for treatment of viral, provliferative and inflammatory diseases |
| 10/27/2004 | CN1541097A 2-amino-4, 5-trisubstituted thiazolyl derivatives |
| 10/27/2004 | CN1541095A 抑制炎症的化合物 The compounds inhibit inflammation |
| 10/27/2004 | CN1541093A Novel use of combined 5-HI1A agonists and selective serotonin reuptake inhibitors |
| 10/27/2004 | CN1541092A Method for treating primary insomnia |
| 10/27/2004 | CN1539970A Heterophil neutral leucocyte factor alpha |
| 10/27/2004 | CN1539837A Analog of nerve growth factor (2S, 4S)-2-(2'substituent)-4-(indole-3-methine) |
| 10/27/2004 | CN1539824A Compounds with analygesic effect |
| 10/27/2004 | CN1539816A IL-8 receptor antagonist |
| 10/27/2004 | CN1539491A Chinese traditional medicine for upper respiratory tract infection |
| 10/27/2004 | CN1539470A External Chinese patent medicines for curing periarthritis humeroscapularis and myotenositis |
| 10/27/2004 | CN1539457A Medicinal liquor for curing rheumatism |
| 10/27/2004 | CN1539449A Magnetism and drug combined type fragrnant baldric for avoiding plague |
| 10/27/2004 | CN1539448A Drug for curing reheumatoid arthritis and atrophic artjritis |
| 10/27/2004 | CN1539437A External use tincture for curing hyperosteogeny as well as arthralgia and myalgia |
| 10/27/2004 | CN1539425A General saponin of stem and leaf of American ginseng in Application of preparing medication for treating mycoarditis |